Cargando…

Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)

Detalles Bibliográficos
Autores principales: Danjuma, Mohammed I., Kaul, Ridhima, Alyaarabi, Tamader, Elsayed, Basant, Elshafei, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933322/
https://www.ncbi.nlm.nih.gov/pubmed/36804360
http://dx.doi.org/10.1016/j.ejim.2023.02.009
_version_ 1784889652240449536
author Danjuma, Mohammed I.
Kaul, Ridhima
Alyaarabi, Tamader
Elsayed, Basant
Elshafei, Mohamed
author_facet Danjuma, Mohammed I.
Kaul, Ridhima
Alyaarabi, Tamader
Elsayed, Basant
Elshafei, Mohamed
author_sort Danjuma, Mohammed I.
collection PubMed
description
format Online
Article
Text
id pubmed-9933322
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-99333222023-02-16 Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19) Danjuma, Mohammed I. Kaul, Ridhima Alyaarabi, Tamader Elsayed, Basant Elshafei, Mohamed Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2023-06 2023-02-16 /pmc/articles/PMC9933322/ /pubmed/36804360 http://dx.doi.org/10.1016/j.ejim.2023.02.009 Text en © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Danjuma, Mohammed I.
Kaul, Ridhima
Alyaarabi, Tamader
Elsayed, Basant
Elshafei, Mohamed
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title_full Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title_fullStr Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title_full_unstemmed Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title_short Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
title_sort colchicine and mortality outcomes in patients with coronavirus disease (covid-19)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933322/
https://www.ncbi.nlm.nih.gov/pubmed/36804360
http://dx.doi.org/10.1016/j.ejim.2023.02.009
work_keys_str_mv AT danjumamohammedi colchicineandmortalityoutcomesinpatientswithcoronavirusdiseasecovid19
AT kaulridhima colchicineandmortalityoutcomesinpatientswithcoronavirusdiseasecovid19
AT alyaarabitamader colchicineandmortalityoutcomesinpatientswithcoronavirusdiseasecovid19
AT elsayedbasant colchicineandmortalityoutcomesinpatientswithcoronavirusdiseasecovid19
AT elshafeimohamed colchicineandmortalityoutcomesinpatientswithcoronavirusdiseasecovid19